MeCP2 action on several systems is suggested by our tissue expression analysis, which reports that genes modulated by MeCP2 are expressed not only in the nervous system, but in other systems such as the immune system, and AD, ALS and MS gene-sets are enriched for interleukin and Toll-like receptor signalling pathways. Here, MECP2 is linked to myeloid sarcoma.